Primary tabs

Afinitor / Votubia (Everolimus)

Newly Marketed
Type of Drug / Device New Molecular Entity
Mechanism of Action mTOr
: mTOR Inhibitor
Company / Institution Novartis
Nonprofit / Government Support N/A
: N/A
Populations Indicated For Drug-resistant focal seizures in Tuberous Sclerosis
ex-US Yes
US Yes
Year on Market 2018 (US); 2017 (Ex-US)
Other Resources

Our Mission

The mission of the Epilepsy Foundation is to lead the fight to overcome the challenges of living with epilepsy and to accelerate therapies to stop seizures, find cures, and save lives.

24/7 helpline